Kabiven Peripheral

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline and Serine, the active ingredients in Kabiven Peripheral, are an amino acid solution presented as a sterile injectable solution for intravenous use. It supplies essential and non‑essential amino acids to support protein synthesis and nitrogen balance in patients who cannot receive enteral feeding, such as those in critical care or with gastrointestinal impairment.

GNH USA supplies Kabiven Peripheral as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinical nutrition teams worldwide.

Kabiven Peripheral is used in parenteral nutrition to provide a balanced amino acid profile for patients who cannot be fed enterally. - Patients unable to receive enteral feeding: delivers a complete mixture of essential and non‑essential amino acids to meet protein and nitrogen requirements. - Malnourished or catabolic patients: supports protein synthesis and helps prevent muscle wasting during acute illness or recovery. - Pre‑ and post‑operative critical care: supplies necessary amino acids to aid wound healing and metabolic stability when oral intake is limited.

Intravenous amino acid solutions may be associated with a range of adverse reactions, varying from mild to severe. Common Side Effects: - Infusion site erythema or pain: mild local irritation at the catheter site. - Hyperglycemia: transient elevation of blood glucose, especially in diabetic patients. - Nausea or vomiting: gastrointestinal discomfort during or after infusion. - Mild fever or chills: low‑grade temperature rise related to infusion. Serious or Rare Side Effects: - Anaphylactic reaction: rare but potentially life‑threatening hypersensitivity. - Severe electrolyte disturbance: dangerous hyperkalemia or hypophosphatemia. - Catheter‑related sepsis: systemic infection arising from contaminated infusion set.

When using Kabiven Peripheral, several precautions should be observed to ensure patient safety and product integrity. - Patient assessment: evaluate nutritional status and renal/hepatic function before initiating therapy. - Monitoring: regularly check blood glucose, electrolytes, and nitrogen balance during infusion. - Compatibility: verify compatibility with other intravenous solutions and medications before mixing. - Rate of infusion: administer at the prescribed rate to avoid fluid overload or metabolic complications. - Contraindications: avoid use in patients with known hypersensitivity to any amino acid component. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Amino acid solutions can interact with certain drugs or clinical conditions, influencing efficacy or safety. Major Interactions (Avoid): - High‑dose insulin therapy: concurrent infusion may cause severe hypoglycemia due to increased glucose utilization. - Calcium or magnesium supplements: can precipitate when mixed directly with amino acid solutions, risking line blockage. Moderate Interactions (Monitor Closely): - Loop diuretics: may exacerbate electrolyte shifts, requiring closer monitoring of potassium and phosphate. - Anticonvulsants (e.g., phenobarbital): may alter amino acid metabolism, necessitating dose adjustments. - Radiographic contrast agents: can affect renal function, so monitor kidney parameters when both are used.